Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Williams, G. M.
Right arrow Articles by Gebhardt, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Williams, G. M.
Right arrow Articles by Gebhardt, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1998 Oxford University Press

other

Nonlinearities in 2-Acetylaminofluorene Exposure Responses for Genotoxic and Epigenetic Effects Leading to Initiation of Carcinogenesis in Rat Liver

G. M. Williams1, M. J. Iatropoulos, C. X. Wang, A. M. Jeffrey, S. Thompson, B. Pittman, M. Palasch* and R. Gebhardt*

American Health Foundation Valhulla, New York 10595 *Physiologisch-Chemisches Institut, University of Tübingen Tübingen, Germany

Received February 26, 1998; accepted May 29, 1998

The dose responses for several effects of low-level limited exposures to 2-acetylaminofluorene (AAF) in the Liven of male Fischer 344 rats were measured and a subsequent phenobarbital tumor promotion regimen was used to manifest initiation of carcinogenesis. Three doses over a 10-fold range yielding cumulative total exposures of 0.126, 0.42, and 1.26 mmol AAF/kg body weight were achieved by daily intragastric instillation for up to 12 weeks with interim terminations. This was followed by 24 weeks administration of 500 ppm phenobarbital (PB) in the diet to promote liver tumor development. At 12 weeks at the end of AAF administration, all exposures produced adducts in liver DNA, measured by 32P postlabeling, and the level of adducts increased with exposure, except that the high exposure did not produce a dose proportional increase. Measurement of arylsulfotransferase activity, a key enzyme in the metabolic activation of AAF, revealed that in livers from the high exposure animals, the enzyme was inhibited. To assess for toxicity, the centrilobular zone of glutamine synthetasepositive hepatocytes was quantified immunohistochemically at 12 weeks. The area of the zone was reduced in the high exposure group and there was a trend to reduction in relationship to exposure. The two lower exposures to AAF produced no increase in cell proliferation, whereas the high exposure resulted in a marked increase, about 8-fold over controls. Initiation was assessed by induction of hepatocellular altered foci (HAF) that expressed the placental form of glutathione S-transferase. AAF induced HAF in the high exposure group, 9-fold at 8 weeks and 170-fold at 12 weeks compared to controls. In rats maintained on PB for 24 weeks after exposure, the multiplicity of HAF increased in controls and comparably in the low and mid exposure groups, but remained at the about the same high level in the high exposure group. The high exposure produced a substantial incidence of benign neoplasms by 12 weeks, and with promotion by 36 weeks, all rats developed hepatocellular neoplasia. In the mid exposure group, only one adenoma occurred at 36 weeks in 17 rats, while in the low expmre group, no liver tumor occurred in 23 rats. Thus, these findings document nonlinearities for some of the effects of AAF, with supralinear effects at the high exposure for cell proliferation and induction of HAF, and a no-observed-effect level for induction of promotable liver neoplasms at the lowest cumulative exposure of 0.126 mmol/kg, in spite of the formation of DNA adducts. We conclude that the effects of this DNA-reactive hepatocarcinogen leading to initiation exhibit nonlinearities and possible thresholds.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
S. Fukushima, H. Wanibuchi, K. Morimura, S. Iwai, D. Nakae, H. Kishida, H. Tsuda, N. Uehara, K. Imaida, T. Shirai, et al.
Existence of a Threshold for Induction of Aberrant Crypt Foci in the Rat Colon with Low Doses of 2-Amino-1-methyl-6-phenolimidazo[4,5-b]pyridine
Toxicol. Sci., July 1, 2004; 80(1): 109 - 114.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
G. M. Williams, M. J. Iatropoulos, and A. M. Jeffrey
Thresholds for the Effects of 2-Acetylaminofluorene in Rat Liver
Toxicol Pathol, February 1, 2004; 32(2_suppl): 85 - 91.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
G. M. Williams and M. J. Iatropoulos
Alteration of Liver Cell Function and Proliferation: Differentiation Between Adaptation and Toxicity
Toxicol Pathol, January 1, 2002; 30(1): 41 - 53.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
G. M. Williams, M. J. Iatropoulos, and A. M. Jeffrey
Mechanistic Basis for Nonlinearities and Thresholds in Rat Liver Carcinogenesis by the DNA-Reactive Carcinogens 2-Acetylaminofluorene and Diethylnitrosamine
Toxicol Pathol, May 1, 2000; 28(3): 388 - 395.
[Abstract] [PDF]


Home page
Toxicol SciHome page
A. Bitsch, N. Hadjiolov, P.-C. Klohn, O. Bergmann, I. Zwirner-Baier, and H.-G. Neumann
Dose Response of Early Effects Related to Tumor Promotion of 2-Acetylaminofluorene
Toxicol. Sci., May 1, 2000; 55(1): 44 - 51.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.